ACADIA PHARMACEUTICALS INC — Director's Dealing 2014

Sep 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2014-09-02

Reporting Person: KAPLAN LESTER J PH D (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-02	Common Stock	M	57692	$1.30	Acquired	66192	Direct
2014-09-02	Common Stock	S	57692	$26.76	Disposed	8500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-02	Stock option (right to buy)	$1.30	M	57692	Disposed	2020-06-10	Common Stock (57692)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2013.

F2: 25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following June 11, 2010.